Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial

Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial have?

Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial has 28 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial published?

Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial has 2021 year in the ScholarIQ index.

What is the open-access status of Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial?

Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial has hybrid oa status in the ScholarIQ index.

What is the DOI of Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial?

The DOI for Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial is on the source record.

What is the PMID of Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial?

The PMID for Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial is on the source record.

What is the OpenAlex record for Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial?

The OpenAlex for Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial is on the source record.